Reversible drying of cells and spermatozoa is a highly specialized field. WhyNotDry brings together leading global experts, so each result significantly advances the state of the art. In the first project year, NIAS identified a previously unknown trehalose transporter that may transform trehalose-loading strategies for improving drying resistance. Parallel work showed that LEA-protein–induced metabolic dormancy enhances cell survival under prolonged cold stress. These achievements reinforce expectations for further breakthroughs.
1.2 Work Carried Out per Work Package
WP1 – Xeroprotectant discovery (M1–28, 80%)
Lead: NIAS; Model: Pv11 cells
• Identified xeroprotectants using omics and reverse genetics.
• Purified, characterized, and validated seven protectants (LEA proteins, plasma peptides, Vitamin E).
• Produced membrane-permeable trehalose; alternative loading methods under evaluation.
• Modeled de/re-hydration; programmable desiccation device tested.
WP2 – Drying media and protocols for mammalian cells (40%)
Lead: NIAS
• Defined desiccation/rehydration conditions: trehalose preloading maintains Pv11 viability; STRT1 mediates efflux; LEA proteins and antioxidants protect against damage.
• Characterized LEA proteins, peptides, and Vitamin E using computational tools; manuscript prepared.
• Induced desiccation tolerance in fibroblasts via LEA proteins and cold stress; publication accepted.
WP3 – Reversible drying in cells, spermatozoa, and embryos (M13–48, 35%)
Leads: UNICA, UNITE
• Developed multiscale models and constructed suitable dryers.
• Conducted embryo desiccation trials; moving to blastocyst-stage optimization.
• Performed sperm desiccation and ICSI trials, yielding six live births; second-generation studies ongoing.
WP4 – Prototype design (M24–40, 20%)
Lead: UBU
• Defined technical requirements based on WP1–3 data.
• Market analysis (InnoDry) shows limited interest in Japan; used to guide prototype strategy.
WP5 – Coordination and sustainability (50%)
• Effective management; report preparation ongoing.
• International meeting planned for May 2026; potential keynote by Prof. Sir Paul Nurse.
• Additional bilateral project submitted for continued Japanese funding.
WP6 – Training and dissemination (50%)
• Active dissemination through talks and outreach.
• Training delivered during secondments and return phases.
• All R&I results published in Q1 journals; ongoing IPR and collaboration development.